Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Irofulven/gemcitabine combination under evaluation in advanced cancers

June 21, 2001

VEGF inhibitors in the AstraZeneca pipeline

June 21, 2001

Cytotoxic topoisomerase inhibitors identified by Rutgers scientists

June 21, 2001

Phase II trial begins to evaluate Angiozyme for the treatment of colorectal cancer

June 21, 2001

Inhibitors of tyrosine kinase from Merck useful as antiangiogenic agents

June 20, 2001

BLS successfully develops GMP manufacturing process for troponin I

June 20, 2001

Synthetic halichondrin B analogues show high antitumor potency and wide therapeutic window

June 20, 2001

Progen receives U.S. approval to begin phase II trial of PI-88

June 20, 2001

Phase I trials commence with Ilex Oncology's ILX-651 and NM-3

June 20, 2001

Metvix PDT receives first approval in Sweden

June 19, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...